CCMI
REGN icon

Creative Capital Management Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Creative Capital Management Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37K Buy
+7
New +$4.76K ﹤0.01% 459

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Creative Capital Management Investments's REGN Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 7 shares worth $4.37K. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings.

334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Creative Capital Management Investments held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #459 holding.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.